Pages that link to "Q34663256"

The following pages link to Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents, and children with diabetes (Q34663256):

Displaying 27 items.

• Continuous subcutaneous insulin infusion in adult type 1 diabetes mellitus: data from a registry at the University Medical Centre Ljubljana, Slovenia (Q30564482) (← links)
• Antecedent caloric intake and glucose excursion following a subsequent meal in Type 1 diabetes (Q34051495) (← links)
• Polymorphisms of GLP-1 receptor gene and response to GLP-1 analogue in patients with poorly controlled type 2 diabetes (Q35133181) (← links)
• Insulin pumps (Q35274358) (← links)
• Use of sensors in the treatment and follow-up of patients with diabetes mellitus. (Q35863010) (← links)
• Clinical review: insulin pump-associated adverse events in adults and children. (Q35669227) (← links)
• Changes in Insulin Requirements From the Onset of Continuous Subcutaneous Insulin Infusion (CSII) Until Optimization of Glycemic Control (Q35682701) (← links)
• Insulin pump therapy is equally effective and safe in elderly and young type 1 diabetes patients. (Q35758485) (← links)
• Are late-night eating habits and sleep duration associated with glycemic control in adult type 1 diabetes patients treated with insulin pumps? (Q35879334) (← links)
• Closed-loop insulin delivery - what lies between where we are and where we are going? (Q36316740) (← links)
• Glucose Variability and β- Cell Response by GLP-1 Analogue added-on CSII for Patients with Poorly Controlled Type 2 Diabetes (Q36320582) (← links)
• Impact of therapeutic advances on hypoglycaemia in type 2 diabetes (Q37071750) (← links)
• New technologies for diabetes: a review of the present and the future (Q38055490) (← links)
• Stability and performance of rapid-acting insulin analogs used for continuous subcutaneous insulin infusion: a systematic review (Q38172313) (← links)
• Sources of glycemic variability--what type of technology is needed? (Q39902171) (← links)
• Boluses in Insulin Therapy (Q42293182) (← links)
• Metabolic control of TYPE 1 Diabetes in children treated with insulin pump therapy (Q42375658) (← links)
• Benefits of continuous subcutaneous insulin infusion on quality of life (Q44702806) (← links)
• Treatment of diabetes mellitus using an external insulin pump in clinical practice (Q46297083) (← links)
• Insulin pump therapy in patients with type 1 diabetes (Q46625413) (← links)
• Type 1 diabetes mellitus and pregnancy (Q46625424) (← links)
• Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability (Q46876719) (← links)
• Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. (Q51565054) (← links)
• Effects of a novel short-term continuous subcutaneous insulin infusion program evaluated by continuous glucose monitoring on young adult type 1 diabetic patients in Taiwan (Q51858156) (← links)
• Statement by the American Association of Clinical Endocrinologists Consensus Panel on Insulin Pump Management (Q57111588) (← links)
• [Continuous subcutaneous insulin infusion in pediatric patients with type 1 diabetes mellitus] (Q82839010) (← links)
• Long-Term Insulin Pump Treatment in Girls with Type 1 Diabetes and Eating Disorders—Is It Feasible? (Q85109577) (← links)